Your browser doesn't support javascript.
loading
Targeted Silencing of NRF2 by rituximab-conjugated nanoparticles increases the sensitivity of chronic lymphoblastic leukemia cells to Cyclophosphamide.
Khodakarami, Atefeh; Kashani, Mahsa Afsari; Nazer, Atefeh; Kheshti, Armin Mahmoudsalehi; Rashidi, Bentolhoda; Karpisheh, Vahid; Masjedi, Ali; Abolhasani, Shiva; Izadi, Sepideh; Bagherifar, Rafieh; Hejazian, Seyyed Sina; Mohammadi, Hamed; Movassaghpour, AliAkbar; Feizi, Abbas Ali Hosseinpour; Hojjat-Farsangi, Mohammad; Jadidi-Niaragh, Farhad.
Afiliación
  • Khodakarami A; Immunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
  • Kashani MA; Department of Immunology, Faculty of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran.
  • Nazer A; Immunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
  • Kheshti AM; Immunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
  • Rashidi B; Immunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
  • Karpisheh V; Immunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
  • Masjedi A; Student Research Committee, Tabriz University of Medical Sciences, Tabriz, Iran.
  • Abolhasani S; Institute of Experimental Hematology, School of Medicine, Technical University of Munich, 81675, Munich, Germany.
  • Izadi S; Center for Translational Cancer Research (TranslaTUM), School of Medicine, Technical University of Munich, 81675, Munich, Germany.
  • Bagherifar R; Immunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
  • Hejazian SS; Immunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
  • Mohammadi H; Immunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
  • Movassaghpour A; Department of Pharmaceutics, Faculty of Pharmacy, Tabriz University of Medical Sciences, Tabriz, Iran.
  • Feizi AAH; Immunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
  • Hojjat-Farsangi M; Non-Communicable Diseases Research Center, Alborz University of Medical Sciences, Karaj, Iran.
  • Jadidi-Niaragh F; Hematology and Oncology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
Cell Commun Signal ; 21(1): 188, 2023 08 01.
Article en En | MEDLINE | ID: mdl-37528446
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Leucemia Linfocítica Crónica de Células B / Nanopartículas Tipo de estudio: Diagnostic_studies Límite: Humans Idioma: En Revista: Cell Commun Signal Año: 2023 Tipo del documento: Article País de afiliación: Irán
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Leucemia Linfocítica Crónica de Células B / Nanopartículas Tipo de estudio: Diagnostic_studies Límite: Humans Idioma: En Revista: Cell Commun Signal Año: 2023 Tipo del documento: Article País de afiliación: Irán